Mydecine Innovations Group Inc (CSE: MYCO) (OTC: MYCOF) (FSE: 0NF), a Canada-based life sciences company, has named former Red Bull marketing executive, Jim Gunning, as its new chief marketing officer, it was reported on Friday.
Gunning has over two decades of experience in marketing. He has served as the managing director of RESQWATER and as a consultant for Blue Sky Biologicals.
In the new role, Gunning will be responsible for helping Mydecine to become a household name, and for developing a marketing campaign around the company's new fungtional mushroom product range under Mydecine Health Sciences, the company's operational branch. The fungtional mushroom product line should be on retail shelves across the US before the end of this year.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer